glp-1 breastfeeding GLP-1s and — Bridges Lactation ❕NEW RESEARCH: GLP-1 & BREASTFEEDING❕

The only FDA-approved oral GLP-1, Rybelsus, required a specialized absorption enhancer called SNAC to achieve roughly 1% bioavailability, and even then must be taken under tightly controlled conditions

Evidence & References Billings LK, et al

Remarkably, there is evidence that GLP-1 agonists can enhance left ventricular ejection fraction, inotropy, coronary blood flow, cardiac output, and vascular endothelial function because of their cardiovascular effects and decrease overall cardiovascular event risks

Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis

Although LVEF incidence was similar in diabetic patients and non-diabetic patients, diabetic HFpEF patients showed a more severe trend of concentric remodeling/hypertrophy, more serious impairment of LV diastolic function and more acute myocardial fibrosis [32, 33]